The Human Immunodeficiency Virus Therapeutics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Human Immunodeficiency Virus Therapeutics Market?
The size of the global human immunodeficiency virus therapeutics market has been expanding robustly in recent years. The market size is expected to increase from $14.11 billion in 2024 to about $14.94 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Human Immunodeficiency Virus Therapeutics Industry?
By 2029, the Human Immunodeficiency Virus Therapeutics market is projected to reach a size of $18.57 billion, growing at a compound annual growth rate (CAGR) of 5.6%.
Download Your Free Sample of the 2025 Human Immunodeficiency Virus Therapeutics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Human Immunodeficiency Virus Therapeutics Market?
The key drivers in the Human Immunodeficiency Virus Therapeutics market are:
• Rising number of HIV patients
• Increase in regular HIV screenings
• Increase in voluntary testing for HIV
• Surge in unprotected sex practices
Global Market Segmentation: Identifying Major Human Immunodeficiency Virus Therapeutics Industry Segments
The human immunodeficiency virus therapeutics market covered in this report is segmented –
1) By Drug Type: Branded Drugs, Generic Drugs
2) By Drug Class: Nucleoside-Analog Reverse Transcriptase Inhibitors (Nrtis), Non-Nucleoside Reverse Transcriptase Inhibitors (Nnrtis), Entry And Fusion Inhibitors, Protease Inhibitors (Pis), Integrase Inhibitors, Coreceptor Antagonists
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
4) By End-user: Hospitals And Clinics, Specialty Centers
Pre-order the 2025 Human Immunodeficiency Virus Therapeutics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Human Immunodeficiency Virus Therapeutics Market?
The key trends in the Human Immunodeficiency Virus Therapeutics market are:
• Technological advancements are shaping the future of the HIV therapeutics market.
• AI-driven drug discovery is an emerging trend in the field.
• Long-acting injectable therapies are growing in popularity.
• Integration of telemedicine and CRISPR-based gene therapy are significant emerging trends.
Who Are the Top Competitors & Leading Players in the Human Immunodeficiency Virus Therapeutics Market?
Major companies in the Human Immunodeficiency Virus Therapeutics market are:
• Pfizer Inc.
• Johnson & Johnson
• F Hoffmann La Roche Ltd.
• Merck & Co. Inc.
• AbbVie Inc.
• Sanofi SA
• Bristol Myers Squibb Company (BMS)
• Novartis International AG
• GlaxoSmithKline plc (GSK)
• Gilead Sciences Inc.
• Moderna Inc.
• BioNTech SE
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim International GmbH
• Aurobindo Pharma Limited
• Cipla Limited
• Hetero Labs Limited
• Gilead Sciences Inc. / Kite Pharma Inc. (for CAR T HIV cure research)
• Vir Biotechnology Inc.
• Theratechnologies Inc.
• CytoDyn Inc.
Regional Dominance: Which Area Leads the Global Human Immunodeficiency Virus Therapeutics Market?
North America was the largest region in the human immunodeficiency virus therapeutics market in 2024
